X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (182) 182
index medicus (148) 148
equilibrative nucleoside transporter-1 (139) 139
gemcitabine (97) 97
deoxycytidine - analogs & derivatives (91) 91
oncology (88) 88
female (78) 78
male (67) 67
pancreatic cancer (67) 67
cancer (60) 60
chemotherapy (59) 59
pharmacology & pharmacy (56) 56
equilibrative nucleoside transporter 1 - metabolism (55) 55
middle aged (55) 55
aged (54) 54
deoxycytidine kinase (54) 54
pancreatic neoplasms - drug therapy (52) 52
adenocarcinoma (48) 48
deoxycytidine - therapeutic use (48) 48
cell line, tumor (45) 45
survival (45) 45
animals (44) 44
equilibrative nucleoside transporter 1 - genetics (42) 42
cell lung-cancer (40) 40
antimetabolites, antineoplastic - therapeutic use (38) 38
adult (36) 36
deoxycytidine - pharmacology (36) 36
expression (34) 34
pancreatic neoplasms - pathology (34) 34
pancreatic neoplasms - metabolism (32) 32
treatment outcome (31) 31
antimetabolites, antineoplastic - pharmacology (30) 30
ribonucleotide reductase (30) 30
pancreatic neoplasms - genetics (29) 29
aged, 80 and over (28) 28
research (28) 28
drug resistance, neoplasm (27) 27
hent1 (27) 27
prognosis (27) 27
resistance (25) 25
analysis (24) 24
biochemistry & molecular biology (23) 23
phase-iii trial (23) 23
gene expression (22) 22
nucleoside transporter (22) 22
nucleosides (22) 22
article (21) 21
gastroenterology & hepatology (21) 21
mice (21) 21
care and treatment (20) 20
genetic aspects (20) 20
therapy (20) 20
adenocarcinoma - drug therapy (19) 19
biological transport (19) 19
adjuvant chemotherapy (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
cytidine deaminase (18) 18
pharmacogenetics (18) 18
reverse transcriptase polymerase chain reaction (18) 18
acute myeloid-leukemia (17) 17
adenocarcinoma - metabolism (17) 17
biomarkers (17) 17
biomarkers, tumor - metabolism (17) 17
cell biology (17) 17
deoxycytidine - administration & dosage (17) 17
deoxycytidine kinase - genetics (17) 17
drug resistance (17) 17
drug therapy (17) 17
gene expression regulation, neoplastic (17) 17
immunohistochemistry (17) 17
proteins (17) 17
randomized controlled-trial (17) 17
pancreatic neoplasms - mortality (16) 16
sensitivity (16) 16
tumor suppressor proteins - genetics (16) 16
antimetabolites, antineoplastic - pharmacokinetics (15) 15
carcinoma, pancreatic ductal - drug therapy (15) 15
disease-free survival (15) 15
health aspects (15) 15
patient outcomes (15) 15
research article (15) 15
cell survival - drug effects (14) 14
drug-resistance (14) 14
kaplan-meier estimate (14) 14
medicine (14) 14
messenger-rna expression (14) 14
cells (13) 13
cytotoxicity (13) 13
deoxycytidine - metabolism (13) 13
dose-response relationship, drug (13) 13
functional-characterization (13) 13
human-equilibrative-nucleoside-transporter-1 hent1 (13) 13
in-vitro (13) 13
medicine & public health (13) 13
metastasis (13) 13
pancreatic neoplasms - therapy (13) 13
physiological aspects (13) 13
polymorphism, single nucleotide (13) 13
predictive value of tests (13) 13
tumor suppressor proteins - metabolism (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 04/2006, Volume 66, Issue 7, pp. 3928 - 3935
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e107973
Journal Article
Pancreas, ISSN 0885-3177, 2014, Volume 43, Issue 3, pp. 350 - 360
This study aimed to evaluate the efficacy of gemcitabine-based chemoradiotherapy followed by surgery (gem-CRTS) for pancreatic ductal adenocarcinoma (PDAC) for... 
Human equilibrative nucleoside transporter 1 expression | Gemcitabine | Resectabilty | Pancreatic cancer | Preoperative chemoradiotherapy | Immunohistochemistry | Outcome Assessment (Health Care) - methods | Multivariate Analysis | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Carcinoma, Pancreatic Ductal - surgery | Deoxycytidine - therapeutic use | CA-19-9 Antigen - analysis | Female | Equilibrative Nucleoside Transporter 1 - analysis | Chemoradiotherapy - methods | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Proportional Hazards Models | Pancreas - drug effects | Carcinoma, Pancreatic Ductal - therapy | Combined Modality Therapy | Pancreas - surgery | Antimetabolites, Antineoplastic - therapeutic use | Outcome Assessment (Health Care) - statistics & numerical data | Adenocarcinoma - therapy | Aged | Pancreas - radiation effects | Deoxycytidine - analogs & derivatives | Adenocarcinoma - surgery | Pancreatectomy - methods | Pancreatic Neoplasms - therapy | CT - computed tomography | NCRT - neoadjuvant chemoradiotherapy | CA - celiac artery | hENT-1 - human equilibrative nucleoside transporter-1 | UR - unresectable | PV - portal vein | SMA - superior mesenteric artery | pancreatic cancer | EMT - epithelial-mesenchymal transition | SMV - superior mesenteric vein | MSTs - median survival times | preoperative chemoradiotherapy | R - resectable | PD - pancreaticoduodenectomy | gem-CRTS - gemcitabine-based chemoradiotherapy followed by surgery | DP - distal pancreatectomy | human equilibrative nucleoside transporter 1 expression | CRT - chemoradiotherapy | resectabilty | AC - adjuvant chemotherapy | BR - borderline resectable | EUS-FNA - endoscopic ultrasonography–guided fine-needle aspiration | PDAC - pancreatic ductal adenocarcinoma | MDCT - multidetector computed tomography | NCCN - National Comprehensive Cancer Network | gemcitabine | UICC - Union Internationale Contre le Cancer | Original
Journal Article
NUCLEAR MEDICINE COMMUNICATIONS, ISSN 0143-3636, 06/2011, Volume 32, Issue 6, pp. 460 - 465
Purpose We examined equilibrative nucleoside transporter-1 (ENT1) and thymidine kinase-1 (TK1) messenger ribonucleic acid (mRNA) expressions in cancer tissue... 
CELLS | MARKER | 3 '-deoxy-3 '-F-18-fluorothymidine | TUMOR RESPONSE | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | equilibrative nucleoside transporter-1 | GASTRIC-CANCER | gastrointestinal cancer | COLORECTAL-CANCER | IN-VIVO | IMAGING PROLIFERATION | positron emission tomography | thymidine kinase-1 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
Journal Article
Cancer, ISSN 0008-543X, 01/2013, Volume 119, Issue 2, pp. 454 - 462
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 09/2014, Volume 12, Issue 1, p. 248
Journal Article
Pancreas, ISSN 0885-3177, 2016, Volume 45, Issue 5, pp. 761 - 771
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 06/2011, Volume 32, Issue 6, pp. 460 - 465
PURPOSEWe examined equilibrative nucleoside transporter-1 (ENT1) and thymidine kinase-1 (TK1) messenger ribonucleic acid (mRNA) expressions in cancer tissue... 
F-fluorothymidine | equilibrative nucleoside transporter-1 | positron emission tomography | thymidine kinase-1 | 3′-deoxy-3 | gastrointestinal cancer
Journal Article
Journal Article